Executive Summary
The life sciences industry in 2026 is undergoing a structural shift from function-driven expertise to capability-driven performance. As...
Executive Summary
Life sciences companies are reducing environmental impact across supply chains in 2026 by redesigning sourcing, manufacturing, and distribution...
Executive Summary
Generative AI is fundamentally reshaping drug discovery in 2026 by shifting the process from iterative, lab-driven experimentation to...